Browsing by Author "Garcia Bonitto, Juan"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: discussion from 16 centres on behalf of the Foro Latam EM Study Group
    (Elsevier B.V., 2022) Ciampi, Ethel; Guerra-Posada, Carolina; Treviño-Frenk, Irene; Cortes-Enriquez, Fernando; Correa-Díaz, Edgar Patricio; Steinberg, Judith; Fragoso, Yara; Garcia Bonitto, Juan; Macias, Miguel Angel; Novarro, Nelson; Carra, Adriana; Vizcarra, Darwin; Vrech, Carlos; Cárcamo Rodríguez, Claudia Andrea
    MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis have been recently published, and they have been fundamental for improving patient care. Implementation of these and previous MAGNIMS recommendations have not been established in many countries. Addressing the local limitations behind these difficulties is needed. A panel of 14 MS neurologists from 16 different reference centres from Chile, Argentina, Mexico, Colombia, Ecuador, Panamá, Perú and Brazil met to discuss the current situation regarding the use of MRI in MS including a) Access and availability, b) Standardized acquisition protocols and reports, and c) Multicentric research potential.
  • No Thumbnail Available
    Item
    Practical issues concerning the use of optical coherence tomography in multiple sclerosis in Latin America: Discussion from 19 centres on behalf of the Foro Latam EM study group
    (Elsevier, 2025) Ciampi Diaz, Ethel Leslie; Garcia, Lorena; Carcamo Oyarzo, Claudio Marcelo; Soler León, Bernardita María; Becker, Jefferson; Carra, Adriana; Correa-Diaz, Edgar; Cortes, Fernando; Garcia Bonitto, Juan; Guerra, Carolina; Macias, Miguel Angel; Martinez, Alejandra; Novarro, Nelson; Rivera-Sarabia, Linda; Rocha, Valeria; Rodriguez, Virginia; Sato, Douglas; Steinberg, Judith; Trevino Frenk, Irene; Vasquez, Guido; Pena, Luis
    The 2024 McDonald Criteria now include the optic nerve as the fifth topography for dissemination in space. Optical coherence tomography (OCT) is a valuable biomarker for the diagnosis, prognosis and monitoring of multiple sclerosis (MS). A panel of MS neurologists from 19 centres across 9 Latin American (LATAM) countries discussed OCT use, access, standardized protocols and research potential. They found inequities in OCT access between private (80%) and public healthcare (44%). Only 9 centres had standardized protocols, 50% of which followed the OSCAR-IB consensus criteria for retinal OCT quality assessment and 53% had a neuro-ophthalmologist. The panel concluded that OCT should be available in all MS centres and that standardized acquisition and reporting, as well as improved knowledge of OCT use, in clinical practice are necessary. OCT has significant research potential in LATAM that requires further development and implementation.
  • No Thumbnail Available
    Item
    Practical issues concerning the use of optical coherence tomography in multiple sclerosis in Latin America: Discussion from 19 centres on behalf of the Foro Latam EM study group
    (2025) Ciampi Diaz, Ethel Leslie; Garcia, Lorena; Carcamo Oyarzo, Claudio Marcelo; Soler León, Bernardita María; Becker, Jefferson; Carra, Adriana; Correa-Diaz, Edgar; Cortes, Fernando; Garcia Bonitto, Juan; Guerra, Carolina; Macias, Miguel Angel; Martinez, Alejandra; Novarro, Nelson; Rivera-Sarabia, Linda; Rocha, Valeria; Rodriguez, Virginia; Sato, Douglas; Steinberg, Judith; Trevino Frenk, Irene; Vasquez, Guido; Pena, Luis
    The 2024 McDonald Criteria now include the optic nerve as the fifth topography for dissemination in space. Optical coherence tomography (OCT) is a valuable biomarker for the diagnosis, prognosis and monitoring of multiple sclerosis (MS). A panel of MS neurologists from 19 centres across 9 Latin American (LATAM) countries discussed OCT use, access, standardized protocols and research potential. They found inequities in OCT access between private (80%) and public healthcare (44%). Only 9 centres had standardized protocols, 50% of which followed the OSCAR-IB consensus criteria for retinal OCT quality assessment and 53% had a neuro-ophthalmologist. The panel concluded that OCT should be available in all MS centres and that standardized acquisition and reporting, as well as improved knowledge of OCT use, in clinical practice are necessary. OCT has significant research potential in LATAM that requires further development and implementation.